SE419440B - Sett att framstella somatostatinanaloger - Google Patents

Sett att framstella somatostatinanaloger

Info

Publication number
SE419440B
SE419440B SE7608300A SE7608300A SE419440B SE 419440 B SE419440 B SE 419440B SE 7608300 A SE7608300 A SE 7608300A SE 7608300 A SE7608300 A SE 7608300A SE 419440 B SE419440 B SE 419440B
Authority
SE
Sweden
Prior art keywords
somatostatin analogs
make
make somatostatin
analogs
somatostatin
Prior art date
Application number
SE7608300A
Other languages
English (en)
Swedish (sv)
Other versions
SE7608300L (sv
Inventor
D F Veber
F W Holly
R G Strachan
W J Paleveda
R F Nutt
R F Hirschmann
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of SE7608300L publication Critical patent/SE7608300L/xx
Publication of SE419440B publication Critical patent/SE419440B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/655Somatostatins
    • C07K14/6555Somatostatins at least 1 amino acid in D-form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1005Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE7608300A 1975-08-08 1976-07-21 Sett att framstella somatostatinanaloger SE419440B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60306775A 1975-08-08 1975-08-08
US68000576A 1976-04-23 1976-04-23

Publications (2)

Publication Number Publication Date
SE7608300L SE7608300L (sv) 1977-02-09
SE419440B true SE419440B (sv) 1981-08-03

Family

ID=27084324

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7608300A SE419440B (sv) 1975-08-08 1976-07-21 Sett att framstella somatostatinanaloger

Country Status (8)

Country Link
JP (1) JPS5219659A (enrdf_load_stackoverflow)
CH (1) CH626328A5 (enrdf_load_stackoverflow)
DE (1) DE2635558A1 (enrdf_load_stackoverflow)
DK (1) DK328876A (enrdf_load_stackoverflow)
FR (1) FR2320109A1 (enrdf_load_stackoverflow)
GB (1) GB1502573A (enrdf_load_stackoverflow)
NL (1) NL7607987A (enrdf_load_stackoverflow)
SE (1) SE419440B (enrdf_load_stackoverflow)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4115554A (en) * 1977-08-29 1978-09-19 Merck & Co., Inc. Somatostatin analogs
LU78191A1 (de) * 1977-09-28 1979-05-25 Ciba Geigy Ag Verfahren zur herstellung von neuen cyclopeptiden
US4139526A (en) * 1977-12-01 1979-02-13 Merck & Co., Inc. Somatostatin analogs
US4140767A (en) * 1977-12-01 1979-02-20 Merck & Co., Inc. Somatostatin analogs
JPS5819669B2 (ja) * 1978-10-28 1983-04-19 白井松新薬株式会社 新規生理活性ペプチド化合物及びその製造法
US4316890A (en) * 1979-03-16 1982-02-23 Ciba-Geigy Corporation Peptides and processes for the manufacture thereof
US4244947A (en) * 1979-08-13 1981-01-13 Ayerst Mckenna And Harrison Inc. Carba decapeptide derivatives of [TYR6 ]-somatostatin
HU198626B (en) * 1986-05-27 1989-11-28 Sandoz Ag Process for producing pharmaceutical compositions comprising somatostatin analogues as active ingredient
US5443815A (en) * 1991-11-27 1995-08-22 Diatech, Inc. Technetium-99m labeled peptides for imaging
ATE166359T1 (de) * 1991-08-09 1998-06-15 Winfried Kolbeck Peptide mit einer lanthionin-brücke
US6017512A (en) * 1992-06-23 2000-01-25 Diatide, Inc. Radiolabeled peptides
US5620675A (en) 1992-06-23 1997-04-15 Diatech, Inc. Radioactive peptides
US5716596A (en) * 1992-06-23 1998-02-10 Diatide, Inc. Radioactively labeled somatostatin-derived peptides for imaging and therapeutic uses
AT401517B (de) * 1993-08-20 1996-09-25 Hafslund Nycomed Pharma Asymmetrisch substituierte diaminodicarbonsäurederivate und ein verfahren zu deren herstellung
EA007649B1 (ru) * 1999-09-08 2006-12-29 Слоан-Кеттеринг Инститьют Фор Кэнсер Рисёч Ингибиторы гистондеацетилазы, вызывающие дифференцировку клеток, и их применение

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6509712A (enrdf_load_stackoverflow) * 1964-07-27 1966-01-28
DE2460469A1 (de) * 1974-12-20 1976-07-01 Hoechst Ag Neue peptide mit biologischer wirkung und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
DK328876A (da) 1977-02-09
DE2635558A1 (de) 1977-02-17
GB1502573A (en) 1978-03-01
CH626328A5 (en) 1981-11-13
SE7608300L (sv) 1977-02-09
FR2320109A1 (fr) 1977-03-04
NL7607987A (nl) 1977-02-10
FR2320109B1 (enrdf_load_stackoverflow) 1979-05-25
JPS5219659A (en) 1977-02-15

Similar Documents

Publication Publication Date Title
SE432247B (sv) Sett att framstella dihydro-cyklosporin c
SE433222B (sv) Sett att framstella modifierad polysackarid
SE422077B (sv) Sett att framstella syntesgas
SE7606280L (sv) Sett att framstella etrar
SE7600277L (sv) Sett att framstella sampolymerisatpulver
SE7805276L (sv) Sett att framstella liposomblandningar
SE433492B (sv) Sett att framstella fenylettiksyraderivat
SE441042B (sv) Sett att pavisa rheumatoida faktorer
SE420728B (sv) Sett att framstella piperazinyliminorifamyciner
SE430887B (sv) Sett att framstella vissa substituerade fenylguanidiner
SE7608799L (sv) Sett att framstella kromanon-(4)
SE419440B (sv) Sett att framstella somatostatinanaloger
SE432256B (sv) Sett att framstella cellulosaalkyletrar
SE427111B (sv) Sett att framstella pilokarpiniumsalter
SE417507B (sv) Sett att framstella 2-arylamino-2-imidazolinderivat
SE429481B (sv) Sett att pavisa hepatit-b-ytantigen genom latexagglutination
SE7606484L (sv) Sett att framstella hoghallfasta cementkonglomerat
SE430687B (sv) Sett att framstella hexanitrostilben
SE7602729L (sv) Sett att framstella nya indolylalkylpiperidiner
SE420602B (sv) Sett att framstella pyrazin-3-metoxi-2-karboxamidderivat
SE429438B (sv) Sett att framstella flexibla sprengemnesformkroppar
SE420732B (sv) Sett att framstella 4-gonen-3-oner
SE424991B (sv) Sett att framstella nya 5-fenyl-oxazolidinoner
SE7604890L (sv) Sett att framstella perkarbonsyralosningar
SE430156B (sv) Sett att framstella 2-subst-1-(omega-aminoalkoxi)-bensener